Care Partner Conversations

Care Partner Conversations is a supportive webinar series led by care partners for care partners. Whether you're a spouse, family member, friend, or someone interested in learning more about the caregiving experience in Parkinson’s disease, this space is for you. Through candid, compassionate conversations, care partners share real-life strategies, helpful resources, and lessons learned along the way. Each session fosters connection, validation, and a deeper understanding of the caregiving journey—because you’re not alone.
Speakers
Barbara Leffler, PhD, RN
Retired Clinical Psychologist and Registered Nurse
Care Partner to her husband living with Parkinson's
Parkinson's Foundation Hospital Lead Ambassador
Terry Thompson, LPC
Senior Editor, Stenhouse Publishers
Nancy Shea, RD, MBA
Business Coach and CASA
Loving Care Partner to husband
Parkinson's Foundation Ambassador with a focus on Care Partner Support
There is no charge to attend, but registration is required. This program is open to people with Parkinson's, their family, friends, and the community.
Contact Us
We want to thank this webinar's sponsor, Amneal, for supporting our mission.

PD Health @ Home is presented by the Light of Day Foundation, whose generosity has made this programming possible.
![]() |
This is a virtual program, taking place live, using the online Zoom platform. Instructions on joining the webinar are provided after registering.
Upcoming Events
2025 Utica Boilermaker Race Weekend
Parkinson’s Champions athletes raise funds and awareness for the Parkinson’s Foundation while competing in some of the world’s most popular races. Every step we take brings us closer to a future without Parkinson’s disease, because Parkinson’s isn’t a sprint, it’s a marathon.
Mindfulness Mondays - Mental Wellbeing
In sessions with Dr. Rush, we explore different dimensions of a mindfulness practice. She will share ways to ground and settle the mind and body.
Exploring the Possibility of Disease-Modifying Therapies
Research aimed at exploring therapies that could possibly change the course of Parkinson’s disease (PD) is rapidly evolving.